Today: 21 May 2026
Ondas Holdings (ONDS) stock climbs again in premarket as $10 million order update ripples through
2 January 2026
1 min read

Ondas Holdings (ONDS) stock climbs again in premarket as $10 million order update ripples through

NEW YORK, Jan 2, 2026, 07:03 ET — Premarket

Ondas Holdings Inc shares rose 3.5% to $10.11 in premarket trading on Friday, extending a sharp late-December rally after the company reported about $10 million in new purchase orders for its autonomous systems business. The stock closed at $9.76 on Dec. 31, up 8.6%, after trading as high as $10.53 on volume of about 156 million shares.

The move matters now because Ondas has become a fast-moving retail and momentum name, with investors treating incremental order news as a read-through on demand for counter-drone and autonomous security systems. The next test is whether the company can turn purchase orders into steady, recurring deliveries as it scales.

Friday’s early gains come as traders weigh a bullish catalyst against fresh evidence of insider selling and the prospect of more shares entering the market. Thin premarket liquidity can also exaggerate moves before the regular U.S. session opens at 9:30 a.m. ET.

Ondas said on Dec. 31 that it received approximately $10 million in orders across its autonomous systems portfolio, including counter-UAS (counter–unmanned aircraft systems, or counter-drone) offerings for critical infrastructure operators, integrated autonomous drone systems and robotic ground platforms for government security customers.

“These new orders underscore the sustained, global demand we are seeing for autonomous air and ground systems,” Chairman and CEO Eric Brock said.

The company also pointed to prior program activity, including counter-UAS deployments at large European airports that it said generated $16.4 million in fourth-quarter orders, and a border-protection effort where it said an initial purchase order is expected in January 2026.

A Form 4 filing with the U.S. Securities and Exchange Commission showed Brock sold 475,000 Ondas shares on Dec. 31 at a weighted average price of about $9.71. Form 4 filings disclose trades by company insiders such as executives and directors.

The filing said the sale was made to cover tax obligations tied to shares issued in connection with an exchange agreement involving Ondas Autonomous Systems, a subsidiary.

In a prior regulatory filing, Ondas said it planned to issue roughly 2.39 million shares on Jan. 5 as part of those exchange agreements and expected to record an estimated $56.6 million one-time non-cash charge for the quarter ended Dec. 31. A non-cash charge is an accounting expense that does not directly use cash but can weigh on reported earnings.

For scale, the $10 million order figure is roughly in line with the $10.1 million in revenue Ondas reported for the third quarter ended Sept. 30, 2025, underscoring why even modest contract updates can move the shares.

Ondas operates through business units that include Ondas Autonomous Systems, which sells drones, counter-drone capabilities and ground robotics, and Ondas Networks, which focuses on private wireless connectivity for industrial customers.

The order update lands in a crowded field where investors also track other defense and drone-adjacent names for sentiment on procurement cycles and security spending, even if individual contract timing can be lumpy.

Stock Market Today

  • Sharda Cropchem Earnings Reveal Weak Cash Flow Despite Profit Growth
    May 20, 2026, 9:35 PM EDT. Sharda Cropchem Limited's (NSE:SHARDACROP) recent earnings report shows a statutory profit of ₹6.81 billion for the year ending March 2026, but free cash flow was significantly lower at ₹1.6 billion, resulting in a high accrual ratio of 0.23. This suggests the company's cash conversion is less than ideal, raising concerns about the sustainability of its earnings. Despite this, Sharda Cropchem's earnings per share (EPS) has grown impressively over the past three years. Investors remain cautious due to three warning signs surrounding the stock, with one marked as significant. The gap between profit and cash flow indicates that reported profits may overstate the company's underlying earning power.

Latest articles

SPAC ETF Up as SpaceX Heads for SPCX Ticker

SPAC ETF Up as SpaceX Heads for SPCX Ticker

21 May 2026
The SPAC and New Issue ETF, now trading as SPCK, closed up 0.64% at $22.09 on Wednesday after SpaceX filed for a $75 billion IPO under the fund’s old ticker. The fund reported $7.14 million in net assets and 41 holdings as of May 19. New listings included a $75 million IPO from Research Alliance III and filings from FutureCorp Space Acquisition 1 and JAB Acquisition I. The SEC proposed easing share issuance rules for public companies.
EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

21 May 2026
EnerSys shares rose in after-hours trading after the company posted fourth-quarter adjusted earnings of $3.19 per share on $988 million in revenue, both above analyst estimates. The stock closed regular hours down 1.3% at $214.56, then quoted up 5.8% to $227. First-quarter profit guidance also topped forecasts. Management cited strong data center and defense demand, but noted continued weakness in motive-power and transportation.
Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

21 May 2026
Silexion Therapeutics shares surged 97% to $0.5298 on Wednesday with over 325 million shares traded, then fell 9.5% after hours. The move followed news that Israel approved a Phase 2/3 trial of its lead pancreatic cancer drug, SIL204. Silexion reported a Q1 net loss of $2.7 million and $2.4 million in cash. The company plans a 1-for-10 reverse share split by early June.
SELLAS (SLS) stock jumps about 10% in premarket as REGAL AML trial milestone stays in focus
Previous Story

SELLAS (SLS) stock jumps about 10% in premarket as REGAL AML trial milestone stays in focus

ASML shares jump after surprise Aletheia upgrade flips outlook on EUV demand
Next Story

ASML shares jump after surprise Aletheia upgrade flips outlook on EUV demand

Go toTop